UKLS trial: looking beyond negative results
- PMID: 34806064
- PMCID: PMC8589705
- DOI: 10.1016/j.lanepe.2021.100184
UKLS trial: looking beyond negative results
Keywords: Lung cancer screening; low-dose computed tomography; lung cancer mortality; public health epidemiology.
Conflict of interest statement
All authors declare no competing interests.
Figures
References
-
- Field John K., Vulkan Daniel, Davies Michael P.A., Baldwin David R., Brain Kate E., Devaraj Anand, et al. Results from the randomised UKLS trial: Lung cancer mortality reduction by LDCT screening confirmed in an international meta-analysis. Lancet Reg Health Europe. 2021 doi: 10.1016/j.lanepe.2021.100179. - DOI - PMC - PubMed
-
- Kauczor H-U, Baird A-M, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, et al. ESR/ERS statement paper on lung cancer screening. Eur Respir J. 2020;55(2) - PubMed
-
- Veronesi G, Maisonneuve P, Rampinelli C, Bertolotti R, Petrella F, Spaggiari L, et al. Computed tomography screening for lung cancer: Results of ten years of annual screening and validation of cosmos prediction model. Lung Cancer. déc. 2013;82(3):426‑30. - PubMed
-
- Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers J-W, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax. 2017;72(1):48‑56. - PubMed
-
- Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. 2012;21(3):308‑15. mai. - PubMed
LinkOut - more resources
Full Text Sources
